Shenzhen VitaVitro Biotech Co., Ltd., a national high-tech corporation, was established in 2015 to provide comprehensive solutions to IVF laboratories all over the world. Products involve oocytes retrieval, vitrification, culture, and embryo transfer, are provided to Europe, North America, Asia-Pacific, and other regions of the world. Numerous products have obtained FDA 510(k) from the United States (vitrification medium, warming medium, cryopreservation tools, 1-step culture medium, flushing buffer medium, gamete buffer medium and more). Additionally, cryopreservation tool has received CE and NMPA. Of these products, vitrification and warming media were developed in cooperation with multiple clinical research centers around the world.

With the rate of 2-3 new products getting FDA every year, VitaVitro continues to develop the international market and aspires to become one of the world’s leading international enterprises integrating R & D and production in IVF.